Six-year Changes in the Prevalence of Obesity and Obesity-related Diseases in Northeastern China from 2007 to 2013

Overview

Journal Sci Rep

Specialty Science

Date 2017 Jan 28

PMID 28128316

Citations 16

Authors

Jing Wu

Hongqin Xu

Xiuting He

Yi Yuan

Chunyan Wang

Jie Sun

Shumei He

Junqi Niu

Affiliations

Soon will be listed here.

Abstract

Obesity and obesity-related diseases are important public health challenges. In this study, we aimed to provide updated trends in the prevalence of these conditions. We conducted two independent cross-sectional surveys of the general population aged 20-75 years in 2007 and 2013 in Jilin, China. A total of 3636 (1719 males) and 1359 (602 males) participants were enrolled in the 2007 and 2013 surveys, respectively. Obesity-related diseases were defined as type 2 diabetes, hypertension, dyslipidemia and non-alcoholic fatty liver disease (NAFLD). The age-standardized prevalence of obesity, overweight, diabetes, pre-diabetes, dyslipidemia and NAFLD increased from 2007 to 2013 from 15.82% to 19.41%, 35.85% to 41.80%, 6.37% to 9.23%, 16.77% to 23.49%., 53.46% to 65.50%, and 23.48% to 44.31% in males, respectively, and from 13.18% to 18.77%, 31.11% to 37.54%, 4.41% to 8.48%, 8.10% to 16.49%, 41.96% to 54.70%, and 17.56% to 43.06% in females, respectively. However, the prevalence of hypertension remained stable (males: 38.10% vs. 38.63% and females: 33.04% vs. 33.01% in 2007 and 2013, respectively). The prevalence of obesity and obesity-related diseases, except for hypertension, increased significantly in the general population in Northeastern China. More targeted measures should be implemented to address the serious challenges presented by these diseases.

Citing Articles

Empagliflozin Reduces Liver Fat in Individuals With and Without Diabetes.

Abdelgani S, Khattab A, Adams J, Baskoy G, Brown M, Clarke G Diabetes Care. 2024; 47(4):668-675.

PMID: 38295394 PMC: 10973912. DOI: 10.2337/dc23-1646.

Development and Validation of a Nomogram Model for Predicting the Risk of Readmission in Patients with Heart Failure with Reduced Ejection Fraction within 1 Year.

Hu Y, Wang X, Xiao S, Huan C, Wu H, Xu T Cardiovasc Ther. 2022; 2022:4143173.

PMID: 36186488 PMC: 9507773. DOI: 10.1155/2022/4143173.

Dysregulation of Circulating miR-24-3p in Children with Obesity and Its Predictive Value for Metabolic Syndrome.

Zhang B, Xing L, Wang B Obes Facts. 2021; 14(5):456-462.

PMID: 34428771 PMC: 8546450. DOI: 10.1159/000515720.

Obesity parameters in relation to lung function levels in a large Chinese rural adult population.

Zeng X, Liu D, An Z, Li H, Song J, Wu W Epidemiol Health. 2021; 43:e2021047.

PMID: 34353001 PMC: 8602009. DOI: 10.4178/epih.e2021047.

Comparing the Anti-diabetic Effect of Sleeve Gastrectomy with Transit Bipartition Against Sleeve Gastrectomy and Roux-en-Y Gastric Bypass Using a Diabetic Rodent Model.

Liu P, Widjaja J, Dolo P, Yao L, Hong J, Shao Y Obes Surg. 2021; 31(5):2203-2210.

PMID: 33507518 DOI: 10.1007/s11695-021-05256-6.

References

AlKerwi A, Pagny S, Lair M, Delagardelle C, Beissel J . Level of unawareness and management of diabetes, hypertension, and dyslipidemia among adults in Luxembourg: findings from ORISCAV-LUX study. PLoS One. 2013; 8(3):e57920. PMC: 3587422. DOI: 10.1371/journal.pone.0057920. View

Lopez-Velazquez J, Silva-Vidal K, Ponciano-Rodriguez G, Chavez-Tapia N, Arrese M, Uribe M . The prevalence of nonalcoholic fatty liver disease in the Americas. Ann Hepatol. 2014; 13(2):166-78. View

Dixon J . The effect of obesity on health outcomes. Mol Cell Endocrinol. 2009; 316(2):104-8. DOI: 10.1016/j.mce.2009.07.008. View

Liu X, Li Y, Li L, Zhang L, Ren Y, Zhou H . Prevalence, awareness, treatment, control of type 2 diabetes mellitus and risk factors in Chinese rural population: the RuralDiab study. Sci Rep. 2016; 6:31426. PMC: 4980764. DOI: 10.1038/srep31426. View

Oguoma V, Nwose E, Richards R . Prevalence of cardio-metabolic syndrome in Nigeria: a systematic review. Public Health. 2015; 129(5):413-23. DOI: 10.1016/j.puhe.2015.01.017. View

Chobanian A, Bakris G, Black H, Cushman W, Green L, Izzo Jr J . Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42(6):1206-52. DOI: 10.1161/01.HYP.0000107251.49515.c2. View

Hou X, Liu Y, Lu H, Ma X, Hu C, Bao Y . Ten-year changes in the prevalence of overweight, obesity and central obesity among the Chinese adults in urban Shanghai, 1998-2007 - comparison of two cross-sectional surveys. BMC Public Health. 2013; 13:1064. PMC: 3833854. DOI: 10.1186/1471-2458-13-1064. View

Li Z, Xue J, Chen P, Chen L, Yan S, Liu L . Prevalence of nonalcoholic fatty liver disease in mainland of China: a meta-analysis of published studies. J Gastroenterol Hepatol. 2013; 29(1):42-51. DOI: 10.1111/jgh.12428. View

Shi X, He S, Tao Y, Wang C, Jiang Y, Feng X . Prevalence of obesity and associated risk factors in Northeastern China. Diabetes Res Clin Pract. 2010; 91(3):389-94. DOI: 10.1016/j.diabres.2010.11.002. View

10.

Antikainen R, Moltchanov V, Chukwuma Sr C, Kuulasmaa K, Marques-Vidal P, Sans S . Trends in the prevalence, awareness, treatment and control of hypertension: the WHO MONICA Project. Eur J Cardiovasc Prev Rehabil. 2006; 13(1):13-29. DOI: 10.1097/00149831-200602000-00004. View

11.

Antiochos P, Marques-Vidal P, Waeber G, Vollenweider P . Five year trends in dyslipidaemia prevalence and management in Switzerland: the CoLaus study. Nutr Metab Cardiovasc Dis. 2015; 25(11):1007-15. DOI: 10.1016/j.numecd.2015.07.011. View

12.

Luo J, Ma Y, Yu Z, Yang Y, Xie X, Ma X . Prevalence, awareness, treatment and control of dyslipidemia among adults in northwestern China: the cardiovascular risk survey. Lipids Health Dis. 2014; 13:4. PMC: 3895843. DOI: 10.1186/1476-511X-13-4. View

13.

. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016; 387(10027):1513-1530. PMC: 5081106. DOI: 10.1016/S0140-6736(16)00618-8. View

14.

Lim S, Vos T, Flaxman A, Danaei G, Shibuya K, Adair-Rohani H . A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2224-60. PMC: 4156511. DOI: 10.1016/S0140-6736(12)61766-8. View

15.

Wang J, Ning X, Yang L, Lu H, Tu J, Jin W . Trends of hypertension prevalence, awareness, treatment and control in rural areas of northern China during 1991-2011. J Hum Hypertens. 2013; 28(1):25-31. DOI: 10.1038/jhh.2013.44. View

16.

Shen X, Vaidya A, Wu S, Gao X . THE DIABETES EPIDEMIC IN CHINA: AN INTEGRATED REVIEW OF NATIONAL SURVEYS. Endocr Pract. 2016; 22(9):1119-29. PMC: 5567749. DOI: 10.4158/EP161199.RA. View

17.

Lin S, Hufanga S, Linhart C, Morrell S, Taylor R, Magliano D . Diabetes and Obesity Trends in Tonga Over 40 Years. Asia Pac J Public Health. 2016; 28(6):475-85. DOI: 10.1177/1010539516645156. View

18.

Wang J, Xu C, Xun Y, Lu Z, Shi J, Yu C . ZJU index: a novel model for predicting nonalcoholic fatty liver disease in a Chinese population. Sci Rep. 2015; 5:16494. PMC: 4645098. DOI: 10.1038/srep16494. View

19.

Xu B, Xu Z, Xu X, Cai Q, Xu Y . Prevalence, awareness, treatment, and control of hypertension among residents in Guangdong Province, China, 2004 to 2007. Circ Cardiovasc Qual Outcomes. 2013; 6(2):217-22. DOI: 10.1161/CIRCOUTCOMES.111.000062. View

20.

Selvin E, Parrinello C, Sacks D, Coresh J . Trends in prevalence and control of diabetes in the United States, 1988-1994 and 1999-2010. Ann Intern Med. 2014; 160(8):517-25. PMC: 4442608. DOI: 10.7326/M13-2411. View